Clinical trials for Adult T-cell leukemia/lymphoma
24 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT07388563Azacitidine and Abatacept in Relapsed or Refractory T-Cell LymphomaNational Cancer Institute (NCI) · PI: Max J Gordon, M.D.
- RECRUITINGPHASE1, PHASE2NCT05745714HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesPrincess Maxima Center for Pediatric Oncology · PI: Michel Zwaan, Prof. Dr.
- RECRUITINGPhase 2NCT07159620Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like PatientsThe First Affiliated Hospital of Soochow University
- RECRUITINGPhase 1NCT07108868A Phase I Dose Finding Study of MB-CART2219.1University Hospital Tuebingen
- RECRUITINGNCT05237986Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell TherapyNational Cancer Institute (NCI) · PI: Pamela L Wolters, Ph.D.
- RECRUITINGPHASE1, PHASE2NCT07008885BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALLChinese PLA General Hospital · PI: Weidong Han, Ph.D
- ACTIVE NOT RECRUITINGPhase 3NCT07541755PD-1 Inhibitors +Venetoclax+CAG Regimens in R/R T-ALLFujian Medical University Union Hospital · PI: Shaoyuan Wang, Pro
- RECRUITINGPhase 2NCT06698003A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1Memorial Sloan Kettering Cancer Center · PI: Steven Horwitz, MD
- RECRUITINGPhase 2NCT06598722BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- RECRUITINGPHASE1, PHASE2NCT06420076Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T CellsEssen Biotech
- RECRUITINGN/ANCT06481241Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALLInstitute of Hematology & Blood Diseases Hospital, China · PI: Jianxiang Wang, Dr
- RECRUITINGPHASE1, PHASE2NCT07075328A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/LymphomaOtsuka Medical Devices Co., Ltd. Japan
- RECRUITINGNCT06131801Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a SolutionChildren's Hospital Medical Center, Cincinnati · PI: Lauren Pommert, MD
- RECRUITINGNCT05978141A Registry for People With T-cell LymphomaMemorial Sloan Kettering Cancer Center · PI: Steven Horwitz, MD
- RECRUITINGPhase 1NCT04848064Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/LymphomaJohn Reneau · PI: John C Reneau, MD, PhD
- ACTIVE NOT RECRUITINGNCT05237245Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)Assistance Publique - Hôpitaux de Paris · PI: Ambroise MARCAIS, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04703192Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)Daiichi Sankyo · PI: Global Clinical Leader
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04571138A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or LymphomaSeattle Children's Hospital · PI: Corinne Summers, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04499573Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALLFederal Research Institute of Pediatric Hematology, Oncology and Immunology · PI: Michael Maschan
- ACTIVE NOT RECRUITINGPhase 1NCT04088864CD22-CAR T Cells in Children and Young Adults With B Cell MalignanciesStanford University · PI: Liora Schultz, MD
- ACTIVE NOT RECRUITINGPhase 1NCT03684889CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or LymphomaSeattle Children's Hospital · PI: Colleen Annesley, MD
- ACTIVE NOT RECRUITINGPhase 1NCT03330691A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ LeukemiaSeattle Children's Hospital · PI: Colleen Annesley, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03113500Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell LymphomaCity of Hope Medical Center · PI: Alex F Herrera
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02028455A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ LeukemiaSeattle Children's Hospital · PI: Colleen Annesley, MD